RDNT
RadNet, Inc.
$58.19
+1.20%
2026-05-08
About RadNet, Inc.
RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States and internationally. The company operates in two segments, Imaging Centers and Digital Health. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretations of breast, lung, and prostate images, as well as solutions for prostate cancer screening. In addition, it develops and delivers AI-powered health informatics solutions to drive quality, efficiency, and outcomes in imaging and radiology; informatics designed for outpatient radiology; and DeepHealth OS, a cloud-native operating system that helps in the operations of the radiology service. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.
Key Fundamentals
Forward P/E
55.66
EPS (TTM)
$-0.25
ROE
1.4%
Revenue Growth (YoY)
14.8%
Profit Margin
-0.9%
Debt/Equity
137.09
Price/Book
4.06
Beta
1.43
Market Cap
$4.47B
Avg Volume (10D)
762K
Recent Breakout Signals
Recent Price Range (60 Days)
60D High
$75.47
60D Low
$52.39
Avg Volume
844K
Latest Close
$58.19
Get breakout alerts for RDNT
Sign up for Breakout Scanner to receive daily notifications when RDNT triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial. No card required.
RadNet, Inc. (RDNT) is listed on the NASDAQ (NASDAQ). Breakout Scanner monitors RDNT daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. RDNT operates in the Healthcare sector within the Diagnostics & Research industry. Data is provided for informational purposes only and does not constitute financial advice.